rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael J. McBreen

EVP & Chief Commercial Officer

Company insider

Files Form 4 as: EVP & Chief Commercial Officer, Integra LifeSciences Holdings.

In numbers

Trades disclosed
72
Buys
0
Sells
6
Bought
$0
Sold
$964K
Companies
1
Companies where not an officer
0
First trade
1 Aug 2020
Last trade
1 Jun 2026
Last filed
3 Jun 2026

Companies traded

Where they are an officer
IART Integra LifeSciences HoldingsOfficer · Medical Devices · last 1 Jun 20260 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jun 2026filed 3 Jun 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—60,372 at $0.00filing
1 Jun 2026filed 3 Jun 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—31,909 at $0.00filing
1 Jun 2026filed 3 Jun 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—60,372 at $0.00filing
1 Jun 2026filed 3 Jun 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—31,909 at $0.00filing
11 Mar 2026filed 12 Mar 2026IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$70K7,247 at $9.61filing
11 Mar 2026filed 12 Mar 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—92,108 at $0.00filing
11 Mar 2026filed 12 Mar 2026IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—92,108 at $0.00filing
11 Mar 2026filed 12 Mar 2026IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$70K7,247 at $9.61filing
10 Mar 2026filed 12 Mar 2026IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$22K2,354 at $9.55filing
10 Mar 2026filed 12 Mar 2026IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$22K2,354 at $9.55filing
11 Mar 2025filed 13 Mar 2025IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—39,132 at $0.00filing
11 Mar 2025filed 13 Mar 2025IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$11K446 at $23.95filing
11 Mar 2025filed 13 Mar 2025IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$38K1,587 at $23.95filing
11 Mar 2025filed 13 Mar 2025IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code A—18,480 at $0.00filing
10 Mar 2025filed 11 Mar 2025IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$28K1,229 at $22.61filing
10 Mar 2025filed 11 Mar 2025IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$24K1,056 at $22.61filing
2 Dec 2024filed 3 Dec 2024IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Sold$41K1,700 at $24.16filing
12 Mar 2024filed 13 Mar 2024IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$56K1,572 at $35.88filing
12 Mar 2024filed 13 Mar 2024IART Integra LifeSciences HoldingsMedical DevicesSEC FORM 4 Code F$16K440 at $35.88filing
11 Mar 2024filed 13 Mar 2024IART Integra LifeSciences Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—28,226 at $0.00filing

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Chantal Veillon-BertelootEVP & Chro · EVP & Chro at Integra Lifesciences Holdings, filing Form 4 there in the last year
Jeffrey MosebrookSVP, Fin & Princ Acct Officer · SVP, Fin & Princ Acct Officer at Integra Lifesciences Holdings, filing Form 4 there in the last year
Robert T. Davis Jr.EVP & President, TR&DT · EVP & President, TR&DT at Integra Lifesciences Holdings, filing Form 4 there in the last year
Harvinder SinghEVP & President, SS · EVP & President, SS at Integra Lifesciences Holdings, filing Form 4 there in the last year
Lea Daniels KnightEVP & Chief Financial Officer · EVP & Chief Financial Officer at Integra Lifesciences Holdings, filing Form 4 there in the last year